Armistice Capital’s AngioDynamics ANGO Stock Holding History

Armistice Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.3M	Buy	1,869,000 +169,000	+10%	+$1.83M	0.38%	54
2025 Q4	$21.8M	Buy	1,700,000 +64,000	+4%	+$790K	0.26%	63
2025 Q3	$18.3M	Buy	1,636,000 +108,185	+7%	+$1.04M	0.27%	59
2025 Q2	$15.2M	Sell	1,527,815 -566,185	-27%	-$5.54M	0.26%	52
2025 Q1	$19.7M	Buy	2,094,000 +1,222,000	+140%	+$12.8M	0.29%	65
2024 Q4	$7.99M	Sell	872,000 -90,000	-9%	-$662K	0.11%	103
2024 Q3	$7.48M	Buy	962,000 +126,000	+15%	+$910K	0.12%	105
2024 Q2	$5.06M	Sell	836,000 -36,000	-4%	-$222K	0.06%	115
2024 Q1	$5.12M	Buy	872,000 +72,000	+9%	+$428K	0.07%	124
2023 Q4	$6.27M	Buy	+800,000	New	+$5.55M	0.09%	114

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Armistice Capital's ANGO Position: Q1 2026 in Review

Armistice Capital increased its AngioDynamics (ANGO) stake by 9.9% in Q1 2026, buying an estimated $1.83M and bringing the position to 1,869,000 shares worth $21.3M. The position accounts for 0.38% of the portfolio, ranked #54.

Armistice Capital first reported a position in ANGO in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.8M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Armistice Capital held 1,869,000 shares of AngioDynamics worth $21.3M as of Q1 2026.
Armistice Capital bought 169,000 AngioDynamics shares in Q1 2026, an estimated $1.83M.
AngioDynamics made up 0.38% of Armistice Capital's portfolio in Q1 2026, its #54 holding.
Armistice Capital first reported a position in AngioDynamics in Q4 2023 and has held it in 10 quarters since.
Armistice Capital's AngioDynamics position peaked at $21.8M in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.